Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Histological analysis of hepatocellular carcinoma treated by intraarterial combined immunochemotherapy.

Hepato-gastroenterology - 1 Jan 2000

Oka M, Hazama S, Suzuki M, Ogura Y, Kobayashi N, Suzuki T

Abstract excerpt

BACKGROUND/AIMS: We have previously reported the efficacy of intraarterial combined immunochemotherapy for 24 patients with unresectable hepatocellular carcinoma. This therapy consists of recombinant interleukin-2, OK-432, adriamycin, cyclophosphamide, and famotidine. We observed a complete response (CR) in 4, partial response (PR) in 3, minor response (MR) in 7, no change (NC) in 7, and progressive disease (PD)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fas Receptor

Share to Immunohistochemistry

Share to Lewis Blood Group Antigens

Share to Liver Neoplasms

Share to Lymphocytes, Tumor-Infiltrating

Share to Phenotype

Source

Identifiers

PMID: 8751216

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Histological analysis of hepatocellular carcinoma treated by intraarterial combined immunochemotherapy.PMID 8751216Read ↗

Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).Semantic proximity Read ↗

Antitumor effect of intratumoral administration of dendritic cell combination with vincristine chemotherapy in a murine fibrosarcoma model.Semantic proximity Read ↗

Up-regulation of Fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillanceSemantic proximity Read ↗

Immune Cell Composition of Liver Hepatocellular Carcinoma and its clinical relevance: A research based on TCGA databaseSemantic proximity Read ↗

[Significance of histological assessment in drug-induced liver injury].Semantic proximity Read ↗

Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8+ T-cell immune responsesSemantic proximity Read ↗

Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.Semantic proximity Read ↗

The Immunostimulative Effect and Mechanisms of a Novel Mouse Anti-Human PD-1 Monoclonal Antibody on Jurkat Lymphocytic Cells Cocultured with Hepatoma CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.